Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00048958 · ClinicalTrials.gov registry record
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
A clinical trial of Multiple Myeloma and Myelodysplastic Syndrome, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- 9,000
- Enrollment target
- 20
- Study locations
NCT00048958 is a study of Multiple Myeloma and Myelodysplastic Syndrome that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 9,000 participants, above the 526-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1611% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT00048958, a study of Multiple Myeloma and Myelodysplastic Syndrome, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- 9,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
Chromosomal analysis or the study of genetic differences in patients previously untreated with AML, ALL, MDS or MM may be helpful in the diagnosis and classification of disease. It may also improve the ability to predict the course of disease and the selection of therapy. Institutions must have either an Alliance-approved cytogeneticist or an agreement from an Alliance-approved main member cytogenetics laboratory to enroll a patient on CALGB 8461. The Alliance Approved Institutional Cytogeneticists list is posted on the Alliance for Clinical Trials in Oncology website.
Conditions Studied
Interventions
- GENETIC cytogenetic analysis
Study Locations (20)
Illinois
- Illinois CancerCare - Bloomington - Bloomington
- St. Joseph Medical Center - Bloomington
- Graham Hospital - Canton
- Illinois CancerCare - Canton - Canton
- Illinois CancerCare - Carthage - Carthage
- Memorial Hospital - Carthage
- University of Illinois Cancer Center - Chicago
- University of Chicago Cancer Research Center - Chicago
California
- Rebecca and John Moores UCSD Cancer Center - La Jolla
- Camino Medical Group - Treatment Center - Mountain View
- Kaiser Permanente Medical Office -Vandever Medical Office - San Diego
- Naval Medical Center - San Diego - San Diego
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
Florida
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital - Fort Lauderdale
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center - Jupiter
- CCOP - Mount Sinai Medical Center - Miami Beach
Delaware
- Tunnell Cancer Center at Beebe Medical Center - Lewes
- CCOP - Christiana Care Health Services - Newark
District of Columbia
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center - Washington D.C.
- Washington Cancer Institute at Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,000 participants |
| Start Date | 1984-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00048958
The ClinicalTrials.gov registry entry for NCT00048958 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 9,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 526-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1611% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which cytogenetic analysis is the first listed.
NCT00048958 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Illinois, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00048958 about?
NCT00048958 is a clinical study titled "Cytogenetic Studies in Acute Leukemia and Multiple Myeloma". Chromosomal analysis or the study of genetic differences in patients previously untreated with AML, ALL, MDS or MM may be helpful in the diagnosis and classification of disease. It may also improve the ability to predict the course of disease and the selection of therapy. Institutions must have eith...
What is the current status of trial NCT00048958?
This trial is currently active not recruiting. The enrollment target is 9,000 participants. The study started on 1984-06.
What conditions does trial NCT00048958 study?
This clinical trial studies the following conditions: Multiple Myeloma, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, Acute Leukemia.
What interventions are being tested in trial NCT00048958?
The interventions under investigation include: cytogenetic analysis (GENETIC).
Who is sponsoring clinical trial NCT00048958?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00048958 being conducted?
This trial has 20 study locations across California, Delaware, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.